Holen Sie sich die Stockscreener-App
9.72
2.11%
-0.21
Schlusskurs vom Vortag:
$9.93
Offen:
$10.02
24-Stunden-Volumen:
2.80M
Relative Volume:
1.06
Marktkapitalisierung:
$2.18B
Einnahmen:
$509.86M
Nettoeinkommen (Verlust:
$165.35M
KGV:
14.34
EPS:
0.6779
Netto-Cashflow:
$107.55M
1W Leistung:
+3.62%
1M Leistung:
+2.21%
6M Leistung:
+5.77%
1J Leistung:
-33.10%
1-Tages-Spanne:
$9.68
$10.29
1-Wochen-Bereich:
$9.25
$10.29
52-Wochen-Spanne:
$7.2101
$20.46
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
9.72 | 2.10B | 509.86M | 165.35M | 107.55M | 0.6779 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Eingeleitet | Canaccord Genuity | Buy |
| 2026-03-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
FLUENCE ENERGY, INC. (FLNC) SHAREHOLDER ALERT Bernstein - GlobeNewswire
ADMA Biologics, Inc. (ADMA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - Yahoo Finance
ADMA Biologics (ADMA), Why Is It Back In The Spotlight? - Yahoo Finance
(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Why Adma Biologics (ADMA) Dipped More Than Broader Market Today - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - Yahoo Finance
ADMA Biologics Inc (ADMA) Stock Analysis: Potential Upside of 86.61% Sparks Investor Interest - DirectorsTalk Interviews
Adma Biologics Stock Price Forecast. Should You Buy ADMA? - StockInvest.us
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know - finance.yahoo.com
ADMA Biologics IncCommon Stock (Nasdaq:ADMA) Price Chart - The Chronicle-Journal
ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech Gem With 84% Upside Potential - DirectorsTalk Interviews
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
ADMA Stock Downgraded By Cantor As ‘Channel Stuffing’ Claims Shake Investor Confidence - Stocktwits
ADMA: Adma Biologics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance
ADMAAdma Biologics Inc Volatility & Greeks - Finviz
ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech With 76% Potential Upside - DirectorsTalk Interviews
Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Trading Systems Reacting to (ADMA) Volatility - Stock Traders Daily
ADMA Tumbles On Slashed Outlook As Short-Seller Aftermath Meets Competitive Headwinds - stocktwits.com
ADMA Biologics: Maybe The Bears Are Right (Rating Downgrade) (NASDAQ:ADMA) - Seeking Alpha
ADMA Biologics Inc (ADMA) Stock Analysis: Exploring A Promising 82% Potential Upside - DirectorsTalk Interviews
ADMA BIOLOGICS, INC. (ADMA) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty - TMX Newsfile
Class action lawsuit filed against ADMA Biologics for misleading investors and undisclosed transactions - Pluang
Law firm probes ADMA Biologics' leadership for possible breaches of fiduciary duty - Pluang
Nomura Small Cap Growth Fund's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
Investigation launched into ADMA Biologics for alleged revenue inflation via channel-stuffing. - Pluang
ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 79% Potential Upside for Investors - DirectorsTalk Interviews
ADMA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
ADMA Biologics Inc (NASDAQ:ADMA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Bank of America Corp DE Raises Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Why ADMA Biologics (ADMA) Is Up 5.6% After Reaffirming 2026 Revenue Guidance And EPS Momentum - Sahm
Behavioral Patterns of ADMA and Institutional Flows - Stock Traders Daily
ADMA|ADMA Biologics Inc|Price:9.540|Chg%:+0.200 - TradingKey
STATE STREET CORP Buys ADMA Biologics Inc (ADMA) -- Shares Look 49% Undervalued on GF Value - GuruFocus
ADMA Biologics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Can Asceniv Help ADMA Stock Combat IG Market Challenges? - Yahoo Finance
ADMA Biologics: The Earnings Reset Still Leaves More Upside (NASDAQ:ADMA) - Seeking Alpha
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adma Biologics Inc-Aktie (ADMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Grossman Jerrold B | Director |
May 12 '26 |
Buy |
8.01 |
12,500 |
100,125 |
513,884 |
| Grossman Jerrold B | Director |
May 11 '26 |
Buy |
8.01 |
12,500 |
100,125 |
501,384 |
| Guiheen Lawrence P. | Director |
Mar 13 '26 |
Option Exercise |
3.66 |
30,000 |
109,800 |
135,520 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,133,777 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Sale |
15.16 |
21,000 |
318,360 |
2,112,777 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):